Swift Biosciences and Vela Diagnostics Sign Licensing Agreement
Wednesday, December 05, 2012
Swift Biosciences, Inc. today announced that it has signed a technology license agreement with Vela Operations Pte. Ltd, the Singapore-based parent of Vela Diagnostics.
Bio-Rad Receives North American Market Penetration Award
Tuesday, November 20, 2012
The award honors the company that has grown market share at the fastest rate in its industry, as measured by revenues or units sold.
LifeTech TaqMan Integrates with Genedata Expressionist for Genomic Profiling
Thursday, November 15, 2012
Genedata partners with Life Technologies to expedite NGS data analysis and real-time PCR-based validation.
Blackpool Teaching Hospital uses Innovative Technology to Reduce MRSA and MSSA
Thursday, November 15, 2012
Impact of rapid screening programmes which help hospital reduce costs by improving quality of care and driving efficiency to be presented at FIS/HIS 2012 Conference.
DNA Variants Explain Over 10% of Inherited Genetic Risk for Heart Disease
Monday, November 12, 2012
About 10.6% of the inherited genetic risk for developing coronary artery disease (CAD) can be explained by specific DNA variations.
Exome Sequencing: Potential Diagnostic Assay for Unexplained Intellectual Disability
Monday, November 12, 2012
Research findings confirming that de novo mutations represent a major cause of previously unexplained intellectual disability were presented at the American Society of Human Genetics 2012 meeting.
VWR International, LLC to Distribute Illumina’s qPCR Portfolio
Monday, November 12, 2012
Dramatically expands sales reach within U.S. market.
Insightful Advice for Avoiding Clonal Deletions
Friday, November 09, 2012
The latest IDT DECODED newsletter provides recommendations for successful DNA cloning.
JAMA Study Demonstrates Efficacy of Life Technologies' Lung Cancer Test
Thursday, November 08, 2012
Genetic test identifies patients at high risk for mortality in the earliest stage of lung cancer. Study suggests test could maximize the benefits of early screening if used in combination with computed tomography.
|
|
|
|
|
|
